Mammography Market Share, Size, Trends, Industry Analysis Report, By Modality (Multimodal, Standalone); By Application (Diagnostic Screening, Advance Imaging, Clinical Review); By Technology; By End-Use; By Region; Segment Forecast, 2022 - 2030
- Published Date:Sep-2022
- Pages: 101
- Format: PDF
- Report ID: PM2597
- Base Year: 2021
- Historical Data: 2018-2020
Report Summary
The global mammography market was valued at USD 2.00 million in 2021 and is expected to grow at a CAGR of 10.1% during the forecast period. The growing demand for the mammography market is expected to be driven by the increasing incidents of breast cancer, and rapid improvement in the technological field are some of the key reasons for the growth of this particular mammography market.
Know more about this report: Request for sample pages
Technological advancement has brought the mammography market as high-end devices provide high-resolution imaging to view, capture, manage, archive, and safeguard digital images and information. This kind of information and documents helps to provide support to both diagnostic workflow and screening, which also helps in the early detection of breast cancer which helps the being with the diagnosis at an early stage.
The COVID-19 pandemic had a negative impact on the growth of the mammography market. Many mammography running centers halted mammographic screening to minimize patient and staff exposure to the virus. However, as the activities resumed from the end of 2020, it led to a steady increase in the demand for this industry.
Rapid growth in technological advancement and new product launches is also a reason for seeing the surge in this mammography market as the firms are also getting approval which creates a new way to modernize breast cancer screening to empower support decision making.
Industry Dynamics
Growth Drivers
According to WHO, breast cancer has been the most common type of cancer among women with a prevalence rate of 11.7%, and it has also been witnessed that Asia has the highest number of the person affected by breast cancer which as compared to the covid period states that the screening rate has seen a surge after the covid period and shows that the people are aware of the technology they have with which this can be found and diagnosed with cancer.
The widespread use of AI technology with the help of which all the physicians will be able to manage the workload more easily, thus eliminating disparities in patient care and accelerating the growth of the market. It is also projected that there will be a surge in screening mammography and hence leading to market expansion in the coming years.
Report Segmentation
The market is primarily segmented based on Modality, Application,end-use, and region.
|
By Modality |
By Application |
By End-Use |
By Region |
|
|
|
|
Know more about this report: Request for sample pages
Hospitals segment accounted for the largest share in 2021
The hospital market segment accounted for the highest revenue share in 2021 owing to the low cost as compared to its counterpart, along with the high-performance characteristics of the product. They are also equipped with both 2D/3D mammography machines.
Having this kind of advanced system enables enhanced patient experience, shorter wait times, and faster examinations. The presence of skilled healthcare professionals further contributes to segment growth. Moreover, increased public and private investments in the healthcare sector as expected to boost the segment growth.
Diagnostic Screening are expected to spearhead the market growth
Diagnostic screening is expected to see a rise over the forecast period; due to the rise in availability of detailed breast imaging services at a very low price and the usage of advanced technologies, and the availability of skilled and expert service makers.
Also, the availability of digital and 3D mammography, whole breast ultrasonography, and breast MRI for high-risk screening diagnosis and treatment planning has boosted diagnostic detection precision which is projected to augment the segment growth over the forcast period.
Asia Pacific is expected to dominate and witness fastest growth over the forecast period
Asia Pacific is the largest region for mammography screening and is expected to witness faster growth over the forecast period owing to the initiatives taken by governments across the countries. In addition, the growth is attributed to the increasing prevalence of breast cancer and rising awareness regarding the usage of mammography market technology.
North America is expected to be the second largest region for mammography on account of the growing penetration of the industry in both the private and public sectors. Furthermore, the additional technological advancement undertaken across the U.S. is likely to have a positive impact on the revenue growth.
Competitive Insight
Some of the major players operating in the global market include Hologic, Fujifilm, Siemens Healthcare, Phillips Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, I.M.S. Srl, Koninklijke Philips NV, Gamma Medica, Inc., Konica Minolta,usiness Solutions India Private Limited, Carestream Health, BMI Biomedical International SRL, Canon Inc, MetaltronicaSpA, PLANNED OY, GENERAL MEDICAL ITALIA, Villa Systems Medical SpA.
Recent Developments
In February 2022, many Industries announced a USD 10 million investment in a novel 82,000-square-foot manufacturing facility for development of new products.
In December 2021, GE advanced a mammographic platform which offered 3D technology using the same low radiation which traditional 2D technology does.
In 2018, Siemens enhanced Syngo.Breast Care a solution that states tomosynthesic reading with AI base features. This will help physicians with an innovative type of interactive decision support for faster, more accurate interpretation of mammography images, enabling radiologists to deliver results within a shorter period of time, transforms their reading workflows and ultimately improves care delivery.
Mammography Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 2.00 Million |
|
Revenue forecast in 2030 |
USD 4.63 Million |
|
CAGR |
10.1% from 2022 - 2030 |
|
Base year |
2019 |
|
Historical data |
2016 - 2018 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
|
Segments covered |
By Modality, By Application, By End-Use, and By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key companies |
Hologic, Fujifilm, Siemens Healthcare, Phillips Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, I.M.S. Srl, Koninklijke Philips NV, Gamma Medica, Inc., Konica Minolta,usiness Solutions India Private Limited, Carestream Health, BMI Biomedical International SRL |
License and Pricing
Purchase Report Sections
- Regional analysis
- Segmentation analysis
- Industry outlook
- Competitive landscape
Connect with experts
Suggested Report
- Glioblastoma Multiforme (GBM) Treatment Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030
- Genomic Biomarkers Market Share, Size, Trends, Industry Analysis Report, 2021 - 2029
- Cloud Performance Management Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030
- Door and Window Automation Market Share, Size, Trends, Industry Analysis Report, 2023 - 2032
- Customer Engagement Solutions Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030
© 2022 Polaris Market Research and Consulting. All rights reserved
